GRESX
Price
$12.79
Change
-$0.07 (-0.54%)
Updated
Sep 20 closing price
VGSNX
Price
$21.46
Change
-$0.07 (-0.33%)
Updated
Sep 20 closing price
Ad is loading...

GRESX vs VGSNX

Header iconGRESX vs VGSNX Comparison
Open Charts GRESX vs VGSNXBanner chart's image
Goldman Sachs Real Estate Securities Svc
Price$12.79
Change-$0.07 (-0.54%)
VolumeN/A
CapitalizationN/A
Vanguard Real Estate Index Institutional
Price$21.46
Change-$0.07 (-0.33%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
GRESX vs VGSNX Comparison Chart
Loading...
VS
GRESX vs. VGSNX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GRESX is a Buy and VGSNX is a Buy.

FUNDAMENTALS
Fundamentals
VGSNX has more cash in the bank: 70.5B vs. GRESX (96.7M). VGSNX pays higher dividends than GRESX: VGSNX (4.01) vs GRESX (1.95). GRESX was incepted earlier than VGSNX: GRESX (26 years) vs VGSNX (21 years). GRESX is a more actively managed with annual turnover of: 35.00 vs. VGSNX (9.00). GRESX has a lower initial minimum investment than VGSNX: GRESX (0) vs VGSNX (5000000). VGSNX annual gain was more profitable for investors over the last year : 26.90 vs. GRESX (21.32). VGSNX return over 5 years is better than : 26.84 vs. GRESX (-13.01).
GRESXVGSNXGRESX / VGSNX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence26 years21 years-
Gain YTD12.58913.45294%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets96.7M70.5B0%
Annual Yield % from dividends1.954.0149%
Returns for 1 year21.3226.9079%
Returns for 3 years-5.243.64-144%
Returns for 5 years-13.0126.84-48%
Returns for 10 years-16.3287.29-19%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KPRX3.620.16
+4.62%
Kiora Pharmaceuticals Inc.
TRU101.141.17
+1.17%
TransUnion
SVRA4.440.01
+0.23%
Savara
KYMR46.44-0.86
-1.82%
Kymera Therapeutics
GALT2.71-0.06
-2.17%
Galectin Therapeutics